Work

Abstract 1358: The selective HDAC6 inhibitor ITF3756 stimulates an antitumor immune response and leads to tumor regression in combination with anti CTLA-4 antibody in a colon carcinoma murine model

Year: 2022

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2022-1358

Authors: Gianluca Fossati, Chiara Ripamonti, Gianluca Caprini, Pietro Pozzi, Elisabetta Galbiati, Paola Cordella, Mattia Marchini, Barbara Vergani, Giovanni Sandrone, Andrea Stevenazzi, Christian Steinkuhler

Institution: Italfarmaco (Italy)

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4282961648

Cites:

Cited by: 1

Related to: 10